Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl

Research output: Contribution to journalArticleResearchpeer review

Authors

Research Organisations

External Research Organisations

  • Hannover Medical School (MHH)
View graph of relations

Details

Original languageEnglish
Article number57
JournalMicrobial cell factories
Volume17
Issue number1
Early online date7 Apr 2018
Publication statusPublished - 2018

Abstract

Background: AmbLOXe is a lipoxygenase, which is up-regulated during limb-redevelopment in the Mexican axolotl, Ambystoma mexicanum, an animal with remarkable regeneration capacity. Previous studies have shown that mammalian cells transformed with the gene of this epidermal lipoxygenase display faster migration and wound closure rate during in vitro wound healing experiments. Results: In this study, the gene of AmbLOXe was codon-optimized for expression in Escherichia coli and was produced in the insoluble fraction as protein aggregates. These inclusion bodies or nanopills were shown to be reservoirs containing functional protein during in vitro wound healing assays. For this purpose, functional inclusion bodies were used to coat cell culture surfaces prior cell seeding or were added directly to the medium after cells reached confluence. In both scenarios, AmbLOXe inclusion bodies led to faster migration rate and wound closure, in comparison to controls containing either no AmbLOXe or GFP inclusion bodies. Conclusions: Our results demonstrate that AmbLOXe inclusion bodies are functional and may serve as stable reservoirs of this enzyme. Nevertheless, further studies with soluble enzyme are also necessary in order to start elucidating the exact molecular substrates of AmbLOXe and the biochemical pathways involved in the wound healing effect.

Keywords

    Active inclusion bodies, AmbLOXe, Axolotl (Ambystoma mexicanum), In vitro wound healing assay, Lipoxygenase, Nanopills

ASJC Scopus subject areas

Cite this

Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl. / Stamm, Anne; Straub, Sarah; Vogt, Peter et al.
In: Microbial cell factories, Vol. 17, No. 1, 57, 2018.

Research output: Contribution to journalArticleResearchpeer review

Stamm A, Straub S, Vogt P, Scheper T, Pepelanova I. Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl. Microbial cell factories. 2018;17(1):57. Epub 2018 Apr 7. doi: 10.1186/s12934-018-0904-0, 10.15488/3376
Download
@article{cde8ee80dab4445fb0835b310ebb13ff,
title = "Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl",
abstract = "Background: AmbLOXe is a lipoxygenase, which is up-regulated during limb-redevelopment in the Mexican axolotl, Ambystoma mexicanum, an animal with remarkable regeneration capacity. Previous studies have shown that mammalian cells transformed with the gene of this epidermal lipoxygenase display faster migration and wound closure rate during in vitro wound healing experiments. Results: In this study, the gene of AmbLOXe was codon-optimized for expression in Escherichia coli and was produced in the insoluble fraction as protein aggregates. These inclusion bodies or nanopills were shown to be reservoirs containing functional protein during in vitro wound healing assays. For this purpose, functional inclusion bodies were used to coat cell culture surfaces prior cell seeding or were added directly to the medium after cells reached confluence. In both scenarios, AmbLOXe inclusion bodies led to faster migration rate and wound closure, in comparison to controls containing either no AmbLOXe or GFP inclusion bodies. Conclusions: Our results demonstrate that AmbLOXe inclusion bodies are functional and may serve as stable reservoirs of this enzyme. Nevertheless, further studies with soluble enzyme are also necessary in order to start elucidating the exact molecular substrates of AmbLOXe and the biochemical pathways involved in the wound healing effect.",
keywords = "Active inclusion bodies, AmbLOXe, Axolotl (Ambystoma mexicanum), In vitro wound healing assay, Lipoxygenase, Nanopills",
author = "Anne Stamm and Sarah Straub and Peter Vogt and Thomas Scheper and Iliyana Pepelanova",
note = "Funding: This work was performed within the framework of the BIOFABRICATION FOR NIFE initiative, financially supported by the Ministry of Economy and Culture (MWK) of Lower Saxony, Germany.",
year = "2018",
doi = "10.1186/s12934-018-0904-0",
language = "English",
volume = "17",
journal = "Microbial cell factories",
issn = "1475-2859",
publisher = "BioMed Central Ltd.",
number = "1",

}

Download

TY - JOUR

T1 - Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl

AU - Stamm, Anne

AU - Straub, Sarah

AU - Vogt, Peter

AU - Scheper, Thomas

AU - Pepelanova, Iliyana

N1 - Funding: This work was performed within the framework of the BIOFABRICATION FOR NIFE initiative, financially supported by the Ministry of Economy and Culture (MWK) of Lower Saxony, Germany.

PY - 2018

Y1 - 2018

N2 - Background: AmbLOXe is a lipoxygenase, which is up-regulated during limb-redevelopment in the Mexican axolotl, Ambystoma mexicanum, an animal with remarkable regeneration capacity. Previous studies have shown that mammalian cells transformed with the gene of this epidermal lipoxygenase display faster migration and wound closure rate during in vitro wound healing experiments. Results: In this study, the gene of AmbLOXe was codon-optimized for expression in Escherichia coli and was produced in the insoluble fraction as protein aggregates. These inclusion bodies or nanopills were shown to be reservoirs containing functional protein during in vitro wound healing assays. For this purpose, functional inclusion bodies were used to coat cell culture surfaces prior cell seeding or were added directly to the medium after cells reached confluence. In both scenarios, AmbLOXe inclusion bodies led to faster migration rate and wound closure, in comparison to controls containing either no AmbLOXe or GFP inclusion bodies. Conclusions: Our results demonstrate that AmbLOXe inclusion bodies are functional and may serve as stable reservoirs of this enzyme. Nevertheless, further studies with soluble enzyme are also necessary in order to start elucidating the exact molecular substrates of AmbLOXe and the biochemical pathways involved in the wound healing effect.

AB - Background: AmbLOXe is a lipoxygenase, which is up-regulated during limb-redevelopment in the Mexican axolotl, Ambystoma mexicanum, an animal with remarkable regeneration capacity. Previous studies have shown that mammalian cells transformed with the gene of this epidermal lipoxygenase display faster migration and wound closure rate during in vitro wound healing experiments. Results: In this study, the gene of AmbLOXe was codon-optimized for expression in Escherichia coli and was produced in the insoluble fraction as protein aggregates. These inclusion bodies or nanopills were shown to be reservoirs containing functional protein during in vitro wound healing assays. For this purpose, functional inclusion bodies were used to coat cell culture surfaces prior cell seeding or were added directly to the medium after cells reached confluence. In both scenarios, AmbLOXe inclusion bodies led to faster migration rate and wound closure, in comparison to controls containing either no AmbLOXe or GFP inclusion bodies. Conclusions: Our results demonstrate that AmbLOXe inclusion bodies are functional and may serve as stable reservoirs of this enzyme. Nevertheless, further studies with soluble enzyme are also necessary in order to start elucidating the exact molecular substrates of AmbLOXe and the biochemical pathways involved in the wound healing effect.

KW - Active inclusion bodies

KW - AmbLOXe

KW - Axolotl (Ambystoma mexicanum)

KW - In vitro wound healing assay

KW - Lipoxygenase

KW - Nanopills

UR - http://www.scopus.com/inward/record.url?scp=85045065835&partnerID=8YFLogxK

U2 - 10.1186/s12934-018-0904-0

DO - 10.1186/s12934-018-0904-0

M3 - Article

C2 - 29626934

AN - SCOPUS:85045065835

VL - 17

JO - Microbial cell factories

JF - Microbial cell factories

SN - 1475-2859

IS - 1

M1 - 57

ER -

By the same author(s)